Browsing: Dermatologic

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and related weight-loss medications have transformed what is achievable through medical weight management.1,2 As larger and faster weight reductions become more common through the growing use of these medications, dermatologists are increasingly encountering the cutaneous trade-offs of that success